Description
A kit of 10 vials of Thymosin Alpha-1. Each vial contains 5mg of lyophilized Thymosin Alpha-1.
Thymosin alpha-1, or Tα1, is a naturally occurring 28-amino-acid peptide derived from prothymosin alpha. It acts primarily as an immunomodulator rather than a broad immune stimulant, influencing T-cell maturation and function, dendritic cells, natural killer cells, and cytokine signaling. A pharmaceutical form, thymalfasin, has been used clinically in several countries.
Its strongest research interest is in conditions involving immune dysfunction, particularly severe infection, chronic viral disease, and as an adjunct in oncology. Potential benefits suggested by the research include improved T-cell and innate immune function, restoration of immune balance during immunosuppression, improved response to infection, and possibly better tolerance or effectiveness of some cancer therapies.
In cancer research, Tα1 has been studied mainly as an adjunct (that is, in addition) to chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Some studies report improvements in immune markers, treatment tolerance, tumor response, or survival.





